Table of Contents

May 1999; 22 (5)

- H C Gerstein
Is glucose a continuous risk factor for cardiovascular mortality?
Diabetes Care May 1999 22:659-660; doi:10.2337/diacare.22.5.659
- Full Text (PDF)
Select this article
- A M Bernard,
- L Anderson,
- C B Cook,
- and L S Phillips
What do internal medicine residents need to enhance their diabetes care?
Diabetes Care May 1999 22:661-666; doi:10.2337/diacare.22.5.661
- Abstract
- Full Text (PDF)
Select this article
- R Rabasa-Lhoret,
- J Garon,
- H Langelier,
- D Poisson,
- and J L Chiasson
Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen.
Diabetes Care May 1999 22:667-673; doi:10.2337/diacare.22.5.667
- Abstract
- Full Text (PDF)
Select this article
- A Wagner,
- A Risse,
- H L Brill,
- V Wienhausen-Wilke,
- M Rottmann,
- K Sondern,
- and B Angelkort
Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application.
Diabetes Care May 1999 22:674-677; doi:10.2337/diacare.22.5.674
- Abstract
- Full Text (PDF)
Select this article
- C C Van Gils,
- L A Wheeler,
- M Mellstrom,
- E A Brinton,
- S Mason,
- and C G Wheeler
Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience.
Diabetes Care May 1999 22:678-683; doi:10.2337/diacare.22.5.678
- Abstract
- Full Text (PDF)
Select this article
- B Rice,
- I Janssen,
- R Hudson,
- and R Ross
Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men.
Diabetes Care May 1999 22:684-691; doi:10.2337/diacare.22.5.684
- Abstract
- Full Text (PDF)
Select this article
- D J Margolis,
- J Kantor,
- and J A Berlin
Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis.
Diabetes Care May 1999 22:692-695; doi:10.2337/diacare.22.5.692
- Abstract
- Full Text (PDF)
Select this article
- B Balkau,
- S Bertrais,
- P Ducimetiere,
- and E Eschwege
Is there a glycemic threshold for mortality risk?
Diabetes Care May 1999 22:696-699; doi:10.2337/diacare.22.5.696
- Abstract
- Full Text (PDF)
Select this article
- A M Delamater,
- K H Shaw,
- E B Applegate,
- I A Pratt,
- M Eidson,
- G X Lancelotta,
- L Gonzalez-Mendoza,
- and S Richton
Risk for metabolic control problems in minority youth with diabetes.
Diabetes Care May 1999 22:700-705; doi:10.2337/diacare.22.5.700
- Abstract
- Full Text (PDF)
Select this article
- L M Hays and
- D O Clark
Correlates of physical activity in a sample of older adults with type 2 diabetes.
Diabetes Care May 1999 22:706-712; doi:10.2337/diacare.22.5.706
- Abstract
- Full Text (PDF)
Select this article
- B J Anderson,
- J Brackett,
- J Ho,
- and L M Laffel
An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control.
Diabetes Care May 1999 22:713-721; doi:10.2337/diacare.22.5.713
- Abstract
- Full Text (PDF)
Select this article
- S C Weller,
- R D Baer,
- L M Pachter,
- R T Trotter,
- M Glazer,
- J E Garcia de Alba Garcia,
- and R E Klein
Latino beliefs about diabetes.
Diabetes Care May 1999 22:722-728; doi:10.2337/diacare.22.5.722
- Abstract
- Full Text (PDF)
Select this article
- E C Kieffer,
- J A Martin,
- and W H Herman
Impact of maternal nativity on the prevalence of diabetes during pregnancy among U.S. ethnic groups.
Diabetes Care May 1999 22:729-735; doi:10.2337/diacare.22.5.729
- Abstract
- Full Text (PDF)
Select this article
- N L Smith,
- S R Heckbert,
- V A Bittner,
- P J Savage,
- J I Barzilay,
- A S Dobs,
- and B M Psaty
Antidiabetic treatment trends in a cohort of elderly people with diabetes. The cardiovascular health study, 1989-1997.
Diabetes Care May 1999 22:736-742; doi:10.2337/diacare.22.5.736
- Abstract
- Full Text (PDF)
Select this article
- R Klein,
- B E Klein,
- S E Moss,
- K J Cruickshanks,
- and P C Brazy
The 10-year incidence of renal insufficiency in people with type 1 diabetes.
Diabetes Care May 1999 22:743-751; doi:10.2337/diacare.22.5.743
- Abstract
- Full Text (PDF)
Select this article
- R J Halbert,
- K M Leung,
- J M Nichol,
- and A P Legorreta
Effect of multiple patient reminders in improving diabetic retinopathy screening. A randomized trial.
Diabetes Care May 1999 22:752-755; doi:10.2337/diacare.22.5.752
- Abstract
- Full Text (PDF)
Select this article
- R de Marco,
- F Locatelli,
- G Zoppini,
- G Verlato,
- E Bonora,
- and M Muggeo
Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.
Diabetes Care May 1999 22:756-761; doi:10.2337/diacare.22.5.756
- Abstract
- Full Text (PDF)
Select this article
- J E Shaw,
- M de Courten,
- E J Boyko,
- and P Z Zimmet
Impact of new diagnostic criteria for diabetes on different populations.
Diabetes Care May 1999 22:762-766; doi:10.2337/diacare.22.5.762
- Abstract
- Full Text (PDF)
Select this article
- B B Duncan,
- M I Schmidt,
- S Offenbacher,
- K K Wu,
- P J Savage,
- and G Heiss
Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study.
Diabetes Care May 1999 22:767-772; doi:10.2337/diacare.22.5.767
- Abstract
- Full Text (PDF)
Select this article
- B Berger,
- G Stenström,
- and G Sundkvist
Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry.
Diabetes Care May 1999 22:773-778; doi:10.2337/diacare.22.5.773
- Abstract
- Full Text (PDF)
Select this article
- E L Harris,
- S H Sherman,
- and A Georgopoulos
Black-white differences in risk of developing retinopathy among individuals with type 2 diabetes.
Diabetes Care May 1999 22:779-783; doi:10.2337/diacare.22.5.779
- Abstract
- Full Text (PDF)
Select this article
- R Renner,
- A Pfützner,
- M Trautmann,
- O Harzer,
- K Sauter,
- and R Landgraf
Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.
Diabetes Care May 1999 22:784-788; doi:10.2337/diacare.22.5.784
- Abstract
- Full Text (PDF)
Select this article
- P Damsbo,
- P Clauson,
- T C Marbury,
- and K Windfeld
A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.
Diabetes Care May 1999 22:789-794; doi:10.2337/diacare.22.5.789
- Abstract
- Full Text (PDF)
Select this article
- M Ciofetta,
- C Lalli,
- P Del Sindaco,
- E Torlone,
- S Pampanelli,
- L Mauro,
- D L Chiara,
- P Brunetti,
- and G B Bolli
Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.
Diabetes Care May 1999 22:795-800; doi:10.2337/diacare.22.5.795
- Abstract
- Full Text (PDF)
Select this article
- A Lindholm,
- J McEwen,
- and A P Riis
Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.
Diabetes Care May 1999 22:801-805; doi:10.2337/diacare.22.5.801
- Abstract
- Full Text (PDF)
Select this article
- N F Butte,
- H W Hsu,
- M Thotathuchery,
- W W Wong,
- J Khoury,
- and P Reeds
Protein metabolism in insulin-treated gestational diabetes.
Diabetes Care May 1999 22:806-811; doi:10.2337/diacare.22.5.806
- Abstract
- Full Text (PDF)
Select this article
- A M Wägner,
- A Pérez,
- F Calvo,
- R Bonet,
- A Castellví,
- and J Ordóñez
Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.
Diabetes Care May 1999 22:812-817; doi:10.2337/diacare.22.5.812
- Abstract
- Full Text (PDF)
Select this article
- M Emoto,
- Y Nishizawa,
- K Maekawa,
- Y Hiura,
- H Kanda,
- T Kawagishi,
- T Shoji,
- Y Okuno,
- and H Morii
Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
Diabetes Care May 1999 22:818-822; doi:10.2337/diacare.22.5.818
- Abstract
- Full Text (PDF)
Select this article
- H Fujita,
- T Narita,
- and S Ito
Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance.
Diabetes Care May 1999 22:823-826; doi:10.2337/diacare.22.5.823
- Abstract
- Full Text (PDF)
Select this article
- M Rix,
- H Andreassen,
- and P Eskildsen
Impact of peripheral neuropathy on bone density in patients with type 1 diabetes.
Diabetes Care May 1999 22:827-831; doi:10.2337/diacare.22.5.827
- Abstract
- Full Text (PDF)
Select this article
- R E Glasgow,
- E B Fisher,
- B J Anderson,
- A LaGreca,
- D Marrero,
- S B Johnson,
- R R Rubin,
- and D J Cox
Behavioral science in diabetes. Contributions and opportunities.
Diabetes Care May 1999 22:832-843; doi:10.2337/diacare.22.5.832
- Abstract
- Full Text (PDF)
- M P Stern
On the need for outcome trials in preventive pharmacology. Lessons from the recent experience with adverse drug reactions.
Diabetes Care May 1999 22:844-845; doi:10.2337/diacare.22.5.844
- Full Text (PDF)
- L Jovanovic
Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Response to Kitzmiller et al.
Diabetes Care May 1999 22:846-848; doi:10.2337/diacare.22.5.846
- Full Text (PDF)
- Z T Bloomgarden
Genes and the cell biology of insulin secretion and insulin resistance.
Diabetes Care May 1999 22:849-853; doi:10.2337/diacare.22.5.849
- Full Text (PDF)
- I B Hirsch
Metformin added to insulin therapy in poorly controlled type 2 diabetes.
Diabetes Care May 1999 22:854; doi:10.2337/diacare.22.5.854b
- Full Text (PDF)
- P Ladyzyński,
- J M Wójcicki,
- E Jóźwicka,
- J Blachowicz,
- and J Krzymień
Reliability of blood glucose self-monitoring and its influence on glycemic control in highly motivated type 1 diabetic patients.
Diabetes Care May 1999 22:854-856; doi:10.2337/diacare.22.5.854a
- Full Text (PDF)
- R A Lawrenson,
- G M Leydon,
- R B Newson,
- and M D Feher
Coronary heart disease in women with diabetes. Positive association with past hysterectomy and possible benefits of hormone replacement therapy.
Diabetes Care May 1999 22:856-857; doi:10.2337/diacare.22.5.856
- Full Text (PDF)
- T G Ferry and
- C C Naum
Orthodeoxia-platypnea due to diabetic autonomic neuropathy.
Diabetes Care May 1999 22:857-859; doi:10.2337/diacare.22.5.857
- Full Text (PDF)
- J A Kiayias,
- E D Vlachou,
- and E L Papadodima
Metformin and lipoprotein(a) levels.
Diabetes Care May 1999 22:859; doi:10.2337/diacare.22.5.859b
- Full Text (PDF)
- F Ovalle and
- D S Bell
Troglitazone's effect on lipoprotein(a) levels.
Diabetes Care May 1999 22:859-860; doi:10.2337/diacare.22.5.859a
- Full Text (PDF)
- H Ben-Ami,
- N Krivoy,
- P Nagachandran,
- A Roguin,
- and Y Edoute
An interaction between digoxin and acarbose.
Diabetes Care May 1999 22:860-861; doi:10.2337/diacare.22.5.860
- Full Text (PDF)
- A S Sacerdote
Hypoglycemic urticaria revisited.
Diabetes Care May 1999 22:861; doi:10.2337/diacare.22.5.861b
- Full Text (PDF)
- S H Chiou,
- C J Chang,
- C K Chou,
- W M Hsu,
- J H Liu,
- and C H Chiang
Increased nitric oxide levels in aqueous humor of diabetic patients with neovascular glaucoma.
Diabetes Care May 1999 22:861-862; doi:10.2337/diacare.22.5.861a
- Full Text (PDF)
- H Isotani and
- K Kameoka
Hypoglycemia associated with maprotiline in a patient with type 1 diabetes.
Diabetes Care May 1999 22:862-863; doi:10.2337/diacare.22.5.862
- Full Text (PDF)
- T Fujisawa,
- H Ikegami,
- T Tsutsui,
- Y Kawaguchi,
- H Ueda,
- M Shintani,
- K Nojima,
- Y Kawabata,
- M Ono,
- M Nishino,
- S Noso,
- K Yamada,
- N Babaya,
- and T Ogihara
Renal tubular function affects glycosuria-related urinary excretion of 1,5-anhydroglucitol.
Diabetes Care May 1999 22:863-864; doi:10.2337/diacare.22.5.863
- Full Text (PDF)
- H W de Valk,
- P L Hardus,
- H J van Rijn,
- and D W Erkelens
Plasma magnesium concentration and progression of retinopathy.
Diabetes Care May 1999 22:864-865; doi:10.2337/diacare.22.5.864
- Full Text (PDF)
- K Rave,
- L Heinemann,
- L Puhl,
- U Gudat,
- J R Woodworth,
- C Weyer,
- and T Heise
Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients.
Diabetes Care May 1999 22:865-866; doi:10.2337/diacare.22.5.865
- Full Text (PDF)
- S Dagogo-Jack,
- C G Fanelli,
- and P E Cryer
Durable reversal of hypoglycemia unawareness in type 1 diabetes.
Diabetes Care May 1999 22:866-867; doi:10.2337/diacare.22.5.866
- Full Text (PDF)
- E H Hathout,
- B N Cockburn,
- J W Mace,
- J Sharkey,
- J Chen-Daniel,
- and G I Bell
A case of hepatocyte nuclear factor-1 alpha diabetes/MODY3 masquerading as type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea.
Diabetes Care May 1999 22:867-868; doi:10.2337/diacare.22.5.867
- Full Text (PDF)
- J M Fernández-Real,
- C Gutiérrez,
- M Broch,
- R Casamitjana,
- J Vendrell,
- and W Ricart
Insulin response to intravenous glucose correlates with plasma levels of the tumor necrosis factor receptor-1.
Diabetes Care May 1999 22:868-870; doi:10.2337/diacare.22.5.868
- Full Text (PDF)
- F Granado Lorencio and
- B Olmedilla Alonso
Oxidative stress and antioxidant supplementation in type I diabetes.
Diabetes Care May 1999 22:870-873; doi:10.2337/diacare.22.5.870
- Full Text (PDF)
- R Davey
Of gestational diabetes, finesse, and an antipodean snark.
Diabetes Care May 1999 22:873-874; doi:10.2337/diacare.22.5.873
- Full Text (PDF)
- J L Kitzmiller,
- E Main,
- B Ward,
- T Theiss,
- and D L Peterson
Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.
Diabetes Care May 1999 22:874-876; doi:10.2337/diacare.22.5.874
- Full Text (PDF)
- Z Kerényi,
- P Stella,
- Z Bosnyák,
- A G Tabák,
- and G Tamás
Association between central adiposity and multimetabolic syndrome in a special cohort of women with prior gestational diabetes.
Diabetes Care May 1999 22:876-877; doi:10.2337/diacare.22.5.876
- Full Text (PDF)
- M Daimon,
- Y Ono,
- T Saito,
- H Yamaguchi,
- A Hirata,
- H Ohnuma,
- M Igarashi,
- H Eguchi,
- H Manaka,
- and T Kato
Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.
Diabetes Care May 1999 22:877-878; doi:10.2337/diacare.22.5.877
- Full Text (PDF)

Current Issue

December 2009, 32 (12)

Is glucose a continuous risk factor for cardiovascular mortality?

What do internal medicine residents need to enhance their diabetes care?

Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal-bolus (ultralente-regular) insulin regimen.

Therapy of severe diabetic ketoacidosis. Zero-mortality under very-low-dose insulin application.

Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience.

Effects of aerobic or resistance exercise and/or diet on glucose tolerance and plasma insulin levels in obese men.

Healing of diabetic neuropathic foot ulcers receiving standard treatment. A meta-analysis.

Is there a glycemic threshold for mortality risk?

Risk for metabolic control problems in minority youth with diabetes.

Correlates of physical activity in a sample of older adults with type 2 diabetes.

An office-based intervention to maintain parent-adolescent teamwork in diabetes management. Impact on parent involvement, family conflict, and subsequent glycemic control.

Latino beliefs about diabetes.

Impact of maternal nativity on the prevalence of diabetes during pregnancy among U.S. ethnic groups.

Antidiabetic treatment trends in a cohort of elderly people with diabetes. The cardiovascular health study, 1989-1997.

The 10-year incidence of renal insufficiency in people with type 1 diabetes.

Effect of multiple patient reminders in improving diabetic retinopathy screening. A randomized trial.

Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study.

Impact of new diagnostic criteria for diabetes on different populations.

Factor VIII and other hemostasis variables are related to incident diabetes in adults. The Atherosclerosis Risk in Communities (ARIC) Study.

Incidence, prevalence, and mortality of diabetes in a large population. A report from the Skaraborg Diabetes Registry.

Black-white differences in risk of developing retinopathy among individuals with type 2 diabetes.

Use of insulin lispro in continuous subcutaneous insulin infusion treatment. Results of a multicenter trial. German Humalog-CSII Study Group.

A double-blind randomized comparison of meal-related glycemic control by repaglinide and glyburide in well-controlled type 2 diabetic patients.

Contribution of postprandial versus interprandial blood glucose to HbA1c in type 1 diabetes on physiologic intensive therapy with lispro insulin at mealtime.

Improved postprandial glycemic control with insulin aspart. A randomized double-blind cross-over trial in type 1 diabetes.

Protein metabolism in insulin-treated gestational diabetes.

Apolipoprotein(B) identifies dyslipidemic phenotypes associated with cardiovascular risk in normocholesterolemic type 2 diabetic patients.

Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.

Abnormality in urinary protein excretion in Japanese men with impaired glucose tolerance.

Impact of peripheral neuropathy on bone density in patients with type 1 diabetes.

Behavioral science in diabetes. Contributions and opportunities.

On the need for outcome trials in preventive pharmacology. Lessons from the recent experience with adverse drug reactions.

Retinopathy risk: what is responsible? Hormones, hyperglycemia, or humalog? Response to Kitzmiller et al.

Genes and the cell biology of insulin secretion and insulin resistance.

Metformin added to insulin therapy in poorly controlled type 2 diabetes.

Reliability of blood glucose self-monitoring and its influence on glycemic control in highly motivated type 1 diabetic patients.

Coronary heart disease in women with diabetes. Positive association with past hysterectomy and possible benefits of hormone replacement therapy.

Orthodeoxia-platypnea due to diabetic autonomic neuropathy.

Metformin and lipoprotein(a) levels.

Troglitazone's effect on lipoprotein(a) levels.

An interaction between digoxin and acarbose.

Hypoglycemic urticaria revisited.

Increased nitric oxide levels in aqueous humor of diabetic patients with neovascular glaucoma.

Hypoglycemia associated with maprotiline in a patient with type 1 diabetes.

Renal tubular function affects glycosuria-related urinary excretion of 1,5-anhydroglucitol.

Plasma magnesium concentration and progression of retinopathy.

Premixed formulations of insulin lispro. Activity profiles in type 1 diabetic patients.

Durable reversal of hypoglycemia unawareness in type 1 diabetes.

A case of hepatocyte nuclear factor-1 alpha diabetes/MODY3 masquerading as type 1 diabetes in a Mexican-American adolescent and responsive to a low dose of sulfonylurea.

Insulin response to intravenous glucose correlates with plasma levels of the tumor necrosis factor receptor-1.

Oxidative stress and antioxidant supplementation in type I diabetes.

Of gestational diabetes, finesse, and an antipodean snark.

Insulin lispro and the development of proliferative diabetic retinopathy during pregnancy.

Association between central adiposity and multimetabolic syndrome in a special cohort of women with prior gestational diabetes.

Increased serum levels of pentosidine, but not carboxymethyl lysine, in type 2 diabetes without obvious diabetic nephropathy.

This Issue

Current Issue

From the Cover